Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Low-Dose Naltrexone Combined With Bupropion to Stop Smoking With Less Weight Gain
This study has been completed.
Study NCT00129246 Information provided by National Institute on Alcohol Abuse and Alcoholism (NIAAA)
First Received: August 9, 2005 Last Updated: November 26, 2007
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Smoking
Nicotine Dependence
Additional conditions recognized in this trial
Tobacco Use Disorder
Weight Gain
More general conditions related to this trial
Body Weight
Body Weight Changes
Disorders of Environmental Origin
Habits
Mental Disorders
Signs and Symptoms
Substance-Related Disorders
Interventions listed in this trial
Naltrexone
Bupropion
More general drug interventions related to this trial
Antidepressive Agents
Antidepressive Agents, Second-Generation
Central Nervous System Agents
Dopamine Agents
Dopamine Uptake Inhibitors
Molecular Mechanisms of Pharmacological Action
Narcotic Antagonists
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Back to top of Main Content
